TP53 and glioma: Stat1, a modulator of genotoxic responses, implicated in glioma stem cell survival [51] was also activated by volasertib mediated treatments in both LN229 and BT115 (Figure 4 F,G) and concert with p53 may interact to enhance DNA damage and apoptosis [52].